FDA Approval: YORVIPATH (PALOPEGTERIPARATIDE) — Type 1 - New Molecular Entity
Endocrinology · Effective 2024-08-09
Specialty intelligence
50 active CMS and MAC reimbursement alerts affect Endocrinology billing teams (Critical-severity changes active) — most recent: FDA Approval: YORVIPATH (PALOPEGTERIPARATIDE) — Type 1 - New Molecular Entity, effective 2024-08-09. Monitored daily across CMS, all 16 MAC jurisdictions, and the Federal Register.
Daily CMS policy updates, MAC LCD revisions, and coding guidance for Endocrinologybilling teams. All alerts sourced directly from CMS — including the Medicare Coverage Database that carries every MAC’s LCDs — and the Federal Register.
Total alerts
50
Average signal
40/100
Sources monitored
9
Latest Endocrinology alerts
50Endocrinology · Effective 2024-08-09
Endocrinology · Effective 2022-05-13
Endocrinology · Effective 2023-11-08
+ 47 more Endocrinology alerts
Sign in to see the full alert feedWhat is Endocrinology reimbursement leakage costing you?
Calculate your ROI with Endocrinology-specific CMS benchmarks pre-populated.
MAC contractor coverage
Endocrinology billing is subject to both national CMS policy and regional MAC contractor Local Coverage Determinations (LCDs). Coverage from all seven A/B contractors — Noridian, CGS, First Coast, NGS, Novitas, Palmetto GBA, and WPS — reaches us through the CMS Medicare Coverage Database, where they publish their LCDs and Billing & Coding Articles; we track it there for updates affecting Endocrinology codes. Coverage criteria vary by contractor jurisdiction.
Get Endocrinology alerts by email — free
Weekly digest of CMS and MAC policy changes for Endocrinology billing teams.
Endocrinology billing is subject to regional Local Coverage Determinations (LCDs) from the 7 A/B Medicare Administrative Contractors: Noridian, CGS Administrators, First Coast Service Options, National Government Services, Novitas Solutions, Palmetto GBA, and WPS Government Health Administrators. Between them they administer the 12 A/B MAC jurisdictions; a further 4 DME MAC jurisdictions are administered by Noridian and CGS. Coverage criteria and medical necessity requirements vary by jurisdiction. CLV Intelligence monitors all 16 MAC jurisdictions daily for LCD updates affecting Endocrinology codes.
CMS updates the Physician Fee Schedule annually, effective January 1, with proposed rules published in the summer and final rules in November. MAC contractors issue LCD updates on a rolling basis throughout the year with no fixed schedule. The Federal Register publishes proposed and final rules affecting Endocrinology reimbursement on a continuous basis. CLV Intelligence monitors all three sources daily and surfaces updates by signal strength.
A Local Coverage Determination (LCD) is a decision by a Medicare Administrative Contractor specifying under what clinical circumstances a particular service is covered within its geographic jurisdiction. For Endocrinology billing teams, LCDs define medical necessity criteria, covered diagnoses, and documentation requirements for specific procedures. Failure to comply with LCD requirements is among the most common causes of Medicare claim denial in Endocrinology practices.
Codes we track for Endocrinology
The CPT/HCPCS and ICD-10 codes most often affected by Endocrinology policy changes we monitor. Each links to its reimbursement-alert history.
Reimbursement guides & resources
Plain-language guides to the policy cycles that drive Endocrinology reimbursement — the fee schedule, ICD-10, HCPCS, and Local Coverage Determinations.
2027 Fee Schedule Guide
How the CY2027 Medicare Physician Fee Schedule works and what to track.
ICD-10 Change Center
The FY2027 ICD-10-CM update cycle and the October 1 effective date.
HCPCS Quarterly Update
How HCPCS Level II changes every quarter — Jan, Apr, Jul, Oct.
Tracking LCD Changes
How LCDs change across every MAC jurisdiction and how to track them.
2027 Prep Checklist
A free, printable checklist for the CY2027 fee schedule cycle.
Other specialties